
EG 427 raises €27m to finance genetic medicines in neuro-urology
EG 427 has announced the successful closing of a €27 million Series B financing round co-led by Andera Partners and Bpifrance – as part of the InnoBio investment strategy. The proceeds from the financing will be used to fund the Phase Ib/IIa development of EG 427’s lead genetic medicine product,… Read More

